P

Inventor

NAPIER MARY A

US17 patents
⚠️ This page may combine multiple inventors who share the name “NAPIER MARY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENENTECH INC

16 patents
US6838554B2Jan 4, 2005

Nucleic acids encoding proteins that stimulate the proliferation of t-lymphocytes

GENENTECH INC33 citations96
US6410708B1Jun 25, 2002

Nucleic acids encoding A-33 related antigen polypeptides

GENENTECH INC71 citations96
US5726290AMar 10, 1998

Soluble analogues of integrins

GENENTECH INC44 citations95
US7390879B2Jun 24, 2008

Secreted and transmembrane polypeptides and nucleic acids encoding the same

GENENTECH INC36 citations92
US7211400B2May 1, 2007

Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens

GENENTECH INC26 citations92
US5726037AMar 10, 1998

Host cells and method of producing soluble analogues of integrins

GENENTECH INC26 citations92
US7419663B2Sep 2, 2008

Treatment of complement-associated disorders

GENENTECH INC33 citations91
US7192589B2Mar 20, 2007

Treatment of inflammatory disorders with STIgMA immunoadhesins

GENENTECH INC36 citations91
US7056736B2Jun 6, 2006

Secreted and transmembrane polypeptides and nucleic acids encoding the same

GENENTECH INC9 citations82
US7196165B2Mar 27, 2007

PRO363 polypeptides

GENENTECH INC6 citations74
US5837486ANov 17, 1998

Method for preparing soluble analogues of integrins

GENENTECH INC8 citations73
US6936254B2Aug 30, 2005

Method of inducing fetal hemoglobin synthesis

GENENTECH INC2 citations63
US7741056B2Jun 22, 2010

Use of A33 antigens and JAM-IT

GENENTECH INC3 citations62
US7317092B2Jan 8, 2008

Secreted and transmembrane polypeptides and nucleic acids encoding the same

GENENTECH INC1 citations52
US7198917B2Apr 3, 2007

Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens

GENENTECH INC0 citations52
US7115713B2Oct 3, 2006

Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens

GENENTECH INC0 citations52

MERCK & CO INC

1 patent